Echocardiographic Markers of Atrial Fibrillation Recurrence Post Radiofrequency Ablation
Recruiting
- Conditions
- Atrial Fibrillation
- Registration Number
- NCT05690529
- Lead Sponsor
- Centro Hospitalar e Universitário de Coimbra, E.P.E.
- Brief Summary
Determine echocardiographic predictors of atrial fibrillation recurrence post radiofrequency Ablation and evaluate markers of low voltage areas on 3D mapping.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- RECRUITING
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
- paroxysmal or persistent ablation
Exclusion Criteria
- previous AF ablation
- previous left atrial ablation
- refusal to give informed consent
- congenital cradiomiopathy
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Recurrence 1 year
- Secondary Outcome Measures
Name Time Method Low voltage areas At procedure
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie atrial fibrillation recurrence after radiofrequency ablation?
How do echocardiographic markers compare to standard-of-care predictors for AFib recurrence post-ablation?
Which biomarkers correlate with low voltage areas on 3D mapping in AFib ablation outcomes?
What adverse events are associated with radiofrequency ablation for atrial fibrillation and how are they managed?
Are there combination therapies or alternative interventions showing promise for AFib recurrence prevention compared to ablation alone?
Trial Locations
- Locations (1)
Centro Hospitalar e Universitário de Coimbra
🇵🇹Coimbra, Portugal
Centro Hospitalar e Universitário de Coimbra🇵🇹Coimbra, PortugalDiogo FernandesContact23940040011750@chuc.min-saude.pt